propofol has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
Excerpt | Relevance | Reference |
---|---|---|
"Propofol is an intravenous anesthetic widely used for sedation and general anesthesia." | 1.37 | Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease. ( Inada, T; Kubo, K; Shingu, K, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kubo, K | 1 |
Inada, T | 1 |
Shingu, K | 1 |
1 other study available for propofol and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
Topics: Animals; Blotting, Western; Cell Separation; Cyclooxygenase 1; Cyclooxygenase 2; Disease Models, Ani | 2011 |